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Background
Individuals with birch pollinosis may show allergic reac-
tions after consumption of soybean-containing food. This
is caused by cross-reaction of IgE directed against the
major birch pollen allergen Bet v 1 with its homologue
Gly m 4 from soybean. Birch pollen allergic subjects with-
out soybean allergy often present IgE binding to Gly m 4.
Objective
To identify IgE epitopes of Gly m 4 in birch pollen-allergic
subjects with and without allergy to soybean.
Methods
Sera from 33 birch pollen-allergic patients with and without
clinical reactivity to soy as determined by oral food chal-
lenge or convincing history of soy allergy were included in
the study. Specific IgE against Bet v 1 and Gly m 4 was
determined by ImmunoCAP. IgE binding of the sera to
rGly m 4 and soy extract was tested in western blot analy-
sis. To predict putative IgE epitopes, 20 IgE-binding phage-
displayed peptide mimics and heptamers representing the
total Gly m 4 amino acid sequence were bioinformatically
mapped onto the molecular surface of Gly m 4. To verify
predicted epitopes, Gly m 4 variants with substituted epi-
tope residues were expressed in and purified from E. coli.
Secondary and tertiary structures were assessed by CD and
NMR spectroscopy. IgE binding of variants was analyzed by
competitive immunoblotting and inhibition ELISA.
Results
Gly m 4- and Bet v 1-specific IgE levels ranged from 0 to
>100 kUA/L in sera of both patient groups. CAP values
were above 3.5 kUA/L in 18 sera (86%) of patients with
clinical soy allergy and in 7 sera (58%) of patients sensi-
tized, but without clinical reactivity to soy, respectively.
Intensity of IgE binding in western blot corresponded to
ImmunoCAP analysis. Bioinformatic mapping resulted in
four distinct epitopes on Gly m 4 surface. Several amino
acid residues were chosen for generation of substitutional
variants. Purified rGly m 4 variants showed a typical Bet v
1-like structure according to CD spectra and 1D-1H-NMR
spectroscopy. IgE binding to several substitutional variants
was reduced, indicating a multiple number of epitopes on
Gly m 4 surface.
Conclusion
No significant differences in Gly m 4-specific IgE binding
could be observed between birch pollen-allergic patients
with and without clinical soy allergy in ImmunoCAP and
immunoblot analysis. However residual IgE reactivity per-
sists in substitutional rGly m 4 variants, indicating the pre-
sence of further IgE epitopes not yet identified.
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